Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher O'Connor

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
American Journal of Physiology. Renal Physiology|February 1, 2021
Epigenetic regulation of arginine vasopressin receptor 2 expression by PAX2 and Pax transcription interacting proteinSaji Abraham, Raghavendra Paknikar, Samina Bhumbra, et al.
JACC. Heart Failure|June 4, 2025
Promoting Representation in Heart Failure Clinical Trials: Recommendations from the Heart Failure CollaboratoryMegha Gupta, Mona Fiuzat, Matthew Dimond, et al.
JACC. Heart Failure|March 14, 2014
Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)Milton Packer, Peter Carson, Uri Elkayam, et al.
JACC. Heart Failure|August 13, 2018
Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes MellitusAbhinav Sharma, Lauren B Cooper, Mona Fiuzat, et al.
American Heart Journal|September 2, 2008
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failureWei Jiang, Christopher O'Connor, Susan G Silva, et al.
Congestive Heart Failure (Greenwich, Conn.)|June 9, 2006
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFTJay N Cohn, Peter E Carson, Christopher O'Connor, et al.
Metabolomics : Official Journal of the Metabolomic Society|May 19, 2015
Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunctionStephen H Boyle, Wayne R Matson, Eric J Velazquez, et al.
Journal of Cardiac Failure|July 3, 2007
Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) studyGerasimos Filippatos, Joseph Rossi, Donald M Lloyd-Jones, et al.
The American Journal of Cardiology|May 2, 2009
Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])Stephen S Gottlieb, Willem J Kop, Stephen J Ellis, et al.
The American Journal of Cardiology|January 17, 2002
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in menJames A Blumenthal, Michael Babyak, Jiang Wei, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
American Journal of Physiology. Renal Physiology|February 1, 2021
Epigenetic regulation of arginine vasopressin receptor 2 expression by PAX2 and Pax transcription interacting proteinSaji Abraham, Raghavendra Paknikar, Samina Bhumbra, et al.
JACC. Heart Failure|June 4, 2025
Promoting Representation in Heart Failure Clinical Trials: Recommendations from the Heart Failure CollaboratoryMegha Gupta, Mona Fiuzat, Matthew Dimond, et al.
JACC. Heart Failure|March 14, 2014
Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)Milton Packer, Peter Carson, Uri Elkayam, et al.
JACC. Heart Failure|August 13, 2018
Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes MellitusAbhinav Sharma, Lauren B Cooper, Mona Fiuzat, et al.
American Heart Journal|September 2, 2008
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failureWei Jiang, Christopher O'Connor, Susan G Silva, et al.
Congestive Heart Failure (Greenwich, Conn.)|June 9, 2006
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFTJay N Cohn, Peter E Carson, Christopher O'Connor, et al.
Metabolomics : Official Journal of the Metabolomic Society|May 19, 2015
Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunctionStephen H Boyle, Wayne R Matson, Eric J Velazquez, et al.
Journal of Cardiac Failure|July 3, 2007
Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) studyGerasimos Filippatos, Joseph Rossi, Donald M Lloyd-Jones, et al.
The American Journal of Cardiology|May 2, 2009
Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])Stephen S Gottlieb, Willem J Kop, Stephen J Ellis, et al.
The American Journal of Cardiology|January 17, 2002
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in menJames A Blumenthal, Michael Babyak, Jiang Wei, et al.
Pageof 14